Trials / Terminated
TerminatedNCT00542347
Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Queen's University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Proton pump inhibitors (PPI) are used to decrease stomach acid secretion. A generic form of omeprazole, one of the PPIs, is on the market. With cheaper than brand name PPIs, it is unclear whether generic omeprazole is as effective clinically. This study compares generic omeprazole with half-dose esomeprazole, the strongest brand name PPI. The half-dose esomeprazole is in fact cheaper than generic omeprazole. Healthy volunteers will take each medication in turn for 7 days and their stomach acid will be measured while taking each medication. We hypothesize that half-dose esomeprazole is better at suppressing stomach acid than generic omeprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole first | * esomeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 * followed by washout for 7 days * generic omeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 |
| DRUG | Generic omeprazole first | * generic omeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 * followed by washout for 7 days * esomeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2017-04-01
- Completion
- 2018-07-01
- First posted
- 2007-10-11
- Last updated
- 2018-07-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00542347. Inclusion in this directory is not an endorsement.